Market Performance Summary
- Closing Price: Immunome (IMNM) ended the 24‑hour trading period at USD 18.26, up 0.45 % from the previous close.
- Volume: Approximately USD 27.8 million of shares were traded in the last 24 hours.
- Shares Outstanding: 113.6 million.
- Market Capitalization: USD 2.1 billion.
- Year‑to‑Date Performance: The stock is down 30.1 % since the end of the previous month.
- Moving Average: The 200‑day simple moving average is USD 22.56.
- 52‑Week Range: The highest price reached USD 30.06 on 19 August 2026; the lowest was USD 14.64 on 7 November 2025.
Comparative Stock Movements (Last 24 Hours)
| Symbol | Recent Change | Current Price (USD) | Market Cap (USD) | P/E Ratio |
|---|---|---|---|---|
| TMDX | –3.14 % | 72.06 | 2.5 bn | 18.99 |
| FBNC | +4.72 % | 63.92 | 2.5 bn | 19.07 |
| GCMG | –1.19 % | 12.62 | 2.5 bn | 22.88 |
| HCI | +1.11 % | 206.68 | 2.5 bn | 8.81 |
| CLOV | –0.42 % | 4.73 | 2.5 bn | — |
Company Profile
Immunome, Inc. is headquartered in Exton, Pennsylvania. The company develops and commercializes novel therapeutic antibodies and medicines aimed at treating various diseases. Immunome’s products are intended for patients in Pennsylvania. The company’s shares are listed on the Nasdaq exchange.
For further information, visit the company’s website at www.immunome.com .
